1. American Psychiatric Association.

Diagnostic and Statistical Manual of Mental

Disorders. 5 ed. Washington DC: American Psychiatric Publishing; 2013.
2. World Health Organization. The Global Burden of Disease 2004 Update.
Switzerland: 2008.
3. Sadock BJ, Sadock VA. Kaplan & Sadock's Pocket Handbook of Clinical
Psychiatry. 5 ed: Lippincott Williams & Wilkins; 2010.
4. Phanthunane P, Vos T, Whiteford H, Bertram M, Udomratn P. Schizophrenia in
Thailand: prevalence and burden of disease. Population Health Metrics. 2010;8(24).
5. Departemen Kesehatan Republik Indonesia. Laporan Hasil Riset Kesehatan
Indonesia (Riskesdas). 2013.
6. LAKIP. Laporan Akuntabilitas Kinerja Pemerintah Rumah Sakit Jiwa Prof.H.B.
Saanin Padang, Sumatera Barat. LAKIP, 2007.
7. Tomás P, Fuentes I, Roder V, Ruiz JC. Cognitive Rehabilitation Programs in
Schizophrenia: Current Status and Perspectives. International Journal of Psychology
and Psychological Therapy. 2010;10(2):191-204.
8. Mamo DC, Kapur S. Antipsychotic. In: Offermanns S, Rosenthal W, editors.
Encyclopedia of Molecular Pharmacology. 2 ed. Berlin: Springer-Verlag; 2008. p.
180. 9. Carmine HM. Antipsychotic. In: Kreutzer JS, DeLuca J, Caplan B, editors.
Encyclopedia of Clinical Neuropsychology. New York: Springer Science+Business
Media; 2010. p. 206.
10. Stahl SM. Stahl's Essential Psychopharmacology Neuroscientific Basis and
Practical Applications. In: Grady MM, editor. 3 ed. New York: Cambridge University
Press; 2008. p. 437.
11. Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S. Antipsychotic
Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized
Controlled Trials. Schizophrenia Bulletin. 2009;35(2):443-57.
12. Barbosa MT, Caramelli P, Maia DP, Cunningham MC, Guerra HL, Lima-Costa
MF, et al. Parkinsonism and Parkinson's disease in the elderly: a community-based
survey in Brazil (the Bambui study). Movement disorders : official journal of the
Movement Disorder Society. 2006;21(6):800-8.43
13. Hashimoto Y, Uno J, Miwa T, Kurihara M, Tanifuji H, Tensho M. Effects of
antipsychotic polypharmacy on side-effects and concurrent use of medications in
schizophrenic outpatients. Psychiatry and Clinical Neurosciences. 2012(66):405-10.
14. Shin H-W, Chung SJ. Drug-Induced Parkinsonism. Journal of Clinical Neurology
(Seoul, Korea). 2012;8(1):15-21.
15. Black DW, Andreasen NC. Introductory Textbook of Psychiatry. 6 ed. Arlington,
VA: American Psychiatric Publishing; 2014.
16. Tamminga CA, Holcomb HH. Phenotype of schizophrenia: a review and
formulation. Molecular psychiatry. 2005;10(1):27-39.
17. Picchioni MM, Murray RM. Schizophrenia. Bmj. 2007;335(7610):91-5